May 26, 2022
Loading...
You are here:  Home  >  Banking & Finance  >  Tri-County Public Companies  >  Earnings  >  Current Article

Atara Biotherapeutics stock falls on details of secondary stock offering

IN THIS ARTICLE

Atara Biotherapeutics stock fell 6.5 percent after the company announced details of its proposed secondary stock offering. The Bay Area company expects to raise $127.75 million with the sale of 7 million of its shares at $18.25 each, according to a filing with the Securities and Exchange Commission on Jan. 3. The offering is expected…

Subscribe

    This article is only available to Business Times subscribers
  • Subscribers: or REGISTER for complete digital access.
  • Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists.
  • Check the STATUS of your Subscription Account.